期刊文献+
共找到10篇文章
< 1 >
每页显示 20 50 100
肝脏CYP450表达与肝细胞癌发生和抗肝癌药物疗效关联的研究进展 被引量:2
1
作者 朱江华 李玲 +3 位作者 罗密 郑丽云 罗慧敏 汤卓红 《广东药科大学学报》 CAS 2023年第4期128-134,共7页
原发性肝癌新诊断病例数在全球癌症中排名第6位,其中,75%~85%病例为肝细胞癌(hepatocellular carcinoma,HCC)。细胞色素P450(cytochrome P450,CYP450)是一个庞大的主要在肝脏表达的负责大多数内、外源性化合物代谢的蛋白家族。近年来,肝... 原发性肝癌新诊断病例数在全球癌症中排名第6位,其中,75%~85%病例为肝细胞癌(hepatocellular carcinoma,HCC)。细胞色素P450(cytochrome P450,CYP450)是一个庞大的主要在肝脏表达的负责大多数内、外源性化合物代谢的蛋白家族。近年来,肝脏CYP450表达差异与HCC发生之间的关联受到越来越广泛的关注。本文综述肝脏CYP450表达与HCC发生以及抗肝癌药物疗效关联的研究进展,为寻找HCC防治潜在靶点、提高抗肝癌药物临床疗效和促进个体化精准用药提供参考。 展开更多
关键词 肝细胞癌 细胞色素P450 抗肝癌药物
下载PDF
纳米制剂在抗肝癌药物中的应用 被引量:2
2
作者 陈建 《中国医药指南》 2012年第3期73-74,共2页
目的探究纳米制剂在抗肝癌药物中的应用治疗效果。方法选取我院自2008年3月至2010年5月诊治的肝癌患者50例,对其进行不同的治疗手段来治疗肝癌,其中男性有30例,女性20例,年龄45岁~78岁之间,平均年龄56.4岁,根据不同的患者的需求,采用... 目的探究纳米制剂在抗肝癌药物中的应用治疗效果。方法选取我院自2008年3月至2010年5月诊治的肝癌患者50例,对其进行不同的治疗手段来治疗肝癌,其中男性有30例,女性20例,年龄45岁~78岁之间,平均年龄56.4岁,根据不同的患者的需求,采用不同的治疗手段,其中选取的患者有25人采用传统的治疗方法,主要手段是化疗,另外25人则采取最新的纳米制剂抗肝癌。对两组患者均进行各组的治疗,并且对患者进行随访,随访时间为1个月,6个月,12个月,2年以上,对患者的各种情况进行评估,以便得到较为直观的对比。结果化疗治疗组1个月存活患者有23例,占92%,6个月存活患者18例,占72%,12个月存活患者10例,占40%,2年以上存活患者5例,占20%,而纳米治疗组的1个月存活患者有24例,占96%,6个月存活患者21例,占84%,12个月存活患者17例,占68%,2年以上存活患者11例,占44%。结论纳米制剂在抗肝癌中针对性高,治疗效果好,值得临床上的推广。 展开更多
关键词 纳米制剂 抗肝癌药物
下载PDF
新的抗肝癌分子靶及相关药物研究 被引量:2
3
作者 胡琼莹 蒋建东 《中国药理学通报》 CAS CSCD 北大核心 2005年第1期2-5,共4页
目前临床上有效的抗肝癌药物很少,普遍存在着疗效差、毒性大、易产生耐药性等问题,发现新的肝癌分子靶,并以此发展高效低毒的抗肝癌药物是解决问题的关键之一。相关研究表明启动子甲基化、肝细胞生长因子及其受体、血管内皮生长因子及... 目前临床上有效的抗肝癌药物很少,普遍存在着疗效差、毒性大、易产生耐药性等问题,发现新的肝癌分子靶,并以此发展高效低毒的抗肝癌药物是解决问题的关键之一。相关研究表明启动子甲基化、肝细胞生长因子及其受体、血管内皮生长因子及其受体、环氧化酶 2可能是抗肝癌药物有效的分子靶,相应的配体化合物已展示了潜在的应用前景。此外三氧化二砷等其他类型的化合物也显示了一定的抗肝癌疗效。 展开更多
关键词 分子靶 抗肝癌药物 甲基化 HGF/C-MET VEGF/ VEGFR COX-2
下载PDF
拜耳抗肝癌药物索拉非尼获准进入中国
4
《制药原料及中间体》 2008年第11期41-41,共1页
德国拜耳制药公司8月28日表示,其抗肝癌药索拉非尼(Nexavar)已经得到中国国家食品药品监督管理局的批准,将正式进入中国肝癌治疗市场。
关键词 中国 肝癌 国家食品药品监督管理局 抗肝癌药物 拜耳制药公司
原文传递
Establishment of a mdr1 Multidrug Resistant Model of Orthotopic Transplantation of Liver Carcinoma on Nude Mice 被引量:1
5
作者 韩宇 陈孝平 《The Chinese-German Journal of Clinical Oncology》 CAS 2005年第2期86-88,共3页
To develop a new method of inducing mdrl multidrug resistance by establishinga nude mice model of orthotopic transplantation of liver carcinoma by sporadic abdominalchemotherapy at intervals. Methods: Hepatocellular c... To develop a new method of inducing mdrl multidrug resistance by establishinga nude mice model of orthotopic transplantation of liver carcinoma by sporadic abdominalchemotherapy at intervals. Methods: Hepatocellular carcinoma HepG2 cell was cultured and injectedsubcutaneously to form the tumor-supplying mice. The tumor bits from the tumor-supplying mice wereimplanted under the envelope of the mice liver and induced by abdominal chemotherapy withPharmorubicin. Physical examination, ultrasonography, spiral CT and operative inspection were usedto examine tumor progression. RT-PCR and immunohistochemistry were adopted to detect the expressionof mdr1-mRNA and its encoded protein P-gp protein (P-gp). Results: There was no operative dead, therate of implanting tumor successfully was 88% (22/25), the rate of implanting secondly successfullywas 100% (3/3), and the rate of inducing successfully was 80% (16/20). The expression of mdrl-mRNAand the P-gp in the inducing group was 23 folds and 13 folds in the control group respectively.Conclusion: We have established an in vivo model of mdr using nude mice transplanted with orthotopicliver neoplasm coupled to chemotherapy. 展开更多
关键词 liver neoplasms GENES MDR mice nude disease models ANIMAL
下载PDF
Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells 被引量:19
6
作者 Xiao-Ping Chen Qi Wang Jian Guan Zhi-Yong Huang Wan-Guang Zhang Bi-Xiang Zhang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第21期3332-3337,共6页
AIM: To reverse the multidrug resistance (MDR) by RNA interference (RNAi)-mediated MDRI suppression in heparoma cells.METHODS: For reversing MDR by RNAi technology, two different short hairpin RNAs (shRNAs) we... AIM: To reverse the multidrug resistance (MDR) by RNA interference (RNAi)-mediated MDRI suppression in heparoma cells.METHODS: For reversing MDR by RNAi technology, two different short hairpin RNAs (shRNAs) were designed and constructed into pGenSil-1 plasmid, respectively. They were then transfected into a highly adriarnycin-resistant HepG2 hepatorna cell line (HepG2/ADM). The RNAi effect on MDR was evaluated by real-time PCR, cell cytotoxicity assay and rhodarnine 123 (Rh123) efflux assy. RESULTS: The stably-transfected clones showed various degrees of reversal of MDR phenotype. Surprisingly, the MDR phenotype was completely reversed in two transfected clones. CONCLUSION: MDR can be reversed by the shRNAmediated MDRI suppression in HepG2/ADM cells, which provides a valuable clue to make multidrug-resistant hepatoma cells sensitive to anti-cancer drugs. 展开更多
关键词 Multidrug resistance SHRNA MDR1 Hepatocellular carcinoma
下载PDF
Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver:A retrospective study 被引量:4
7
作者 Julien Edeline Jean-Luc Raoul +3 位作者 Elodie Vauleon Anne Guillygomac'h Karim Boud jema Eveline Boucher 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第6期713-716,共4页
AIM:To investigate the efficacy and toxicity of systemic chemotherapy in a retrospective study of patients with hepatocellular carcinoma(HCC)occurring in normal or fibrotic liver without cirrhosis. METHODS:Twenty-four... AIM:To investigate the efficacy and toxicity of systemic chemotherapy in a retrospective study of patients with hepatocellular carcinoma(HCC)occurring in normal or fibrotic liver without cirrhosis. METHODS:Twenty-four patients with metastatic or locally advanced HCC in a normal or a fibrotic liver were given systemic chemotherapy(epirubicin,cis- platin and 5-fluorouracil or epirubicin,cisplatin and capecitabine regimens).Tumor response,time to pro- gression,survival,and toxicity were evaluated. RESULTS:There were 7 women and 17 men,mean age 54±10 years;18 patients had a normal liver and 6 had a fibrotic liver(F1/F2 on biopsy).Mean tumor size was 14 cm,5 patients had portal vein thrombosis and 7 had metastasis.Patients received a median of 4 chemotherapy sessions.Overall tolerance was good. There were 5 partial responses(objective response rate =22%),and tumor control rate was 52%.Second line surgical resection was possible in two patients.Median survival was 11 mo,and 1-and 2-year overall survival rates were 50%±10%and 32%±11%,respectively. CONCLUSION:In patients with HCC in a non-cirrhotic liver,chemotherapy was well tolerated and associated with an objective response rate of 22%,including two patients who underwent secondary surgical resection. 展开更多
关键词 Antineoplastic protocols CHEMOTHERAPY Hepatocellular carcinoma
下载PDF
Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition 被引量:8
8
作者 Satoshi Mamori Tadashi Asakura +1 位作者 Kiyoshi Ohkawa Hisao Tajiri 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第40期5306-5311,共6页
AIM: To investigate the expression of survivin during the early stages of hepatocellular cardnoma (HCC).METHODS: Immunohistochemical expression of survivin in liver tumor and non-tumor tissue specimens taken from ... AIM: To investigate the expression of survivin during the early stages of hepatocellular cardnoma (HCC).METHODS: Immunohistochemical expression of survivin in liver tumor and non-tumor tissue specimens taken from 17 patients was compared. In addition, to determine the survivin expression in response to anticancer drugs in early stage HCC, the survivin expression was determined after the treatment of the HCC cells with anti-cancer drugs under hypoxic culture conditions.RESULTS: Survivin proteins were expressed in 64.7% of cells in early HCC specimens. A correlation between the survivin expression rate in the peritumoral hepatocytes and the rate of expression in the HCC specimens (low-rate group vs high-rate group) was observed. The survivin protein concentration in HCC cells was increased by the combination of hypoxia and anti-cancer drugs.CONCLUSION: This study suggests that survivin could be used as a therapeutic target in early HCC. 展开更多
关键词 SURVIVIN Hepatocellular carcinoma HYPOXIA
下载PDF
Synergistic effect of bromocriptine and tumor necrosis factor-a on reversing hepatoceiiuiar carcinoma multidrug resistance in nude mouse MDRl model of liver neoplasm 被引量:4
9
作者 Lei Ding Xiao-Ping Chen +5 位作者 Zhi-Wei Zhang Jian Guan Wan-Guang Zhang Hai-Ping Wang Zhi-Hui Wang Chun-Lei Li 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第36期5621-5626,共6页
AIM: To investigate the effect of bromocripUne (BCT) and tumor necrosis factor-α ClNF-α) on hepatocellular carcinoma (HCC) multidrug resistance (MDR) in nude mouse HDR model of liver neoplasm. METHODS: Huma... AIM: To investigate the effect of bromocripUne (BCT) and tumor necrosis factor-α ClNF-α) on hepatocellular carcinoma (HCC) multidrug resistance (MDR) in nude mouse HDR model of liver neoplasm. METHODS: Human hepatocarcinoma cell line HepG2t drug resistant hepatocarcinoma cell line HepG2/adriamycin (ADM) and hepatocarcinoma cell line transfected with TNF-α gene HepG2JADM/TNF were injected into the liver of nude mice via orthotopic implantation and MDR model of liver neoplasm in vivo was established (HepG2t ADM, TNF, BCT groups). Among these groups, BCT group and TNF group were treated with BCT through gastric canal. Each group was divided into control group and chemotherapy group. Size and weight of the tumor were measured. Furthermore, tumor his^logical character and growth of the nude mice were observed and their chemosensitivity was tested. MDR-associated genes and proteins (MRP, LRP) of implanted tumors were detected by immunohistochemistry, reverse transcriptase polymerase chain reaction, and apoptosis rate of hepatocarcinoma cells was detected by TUNEL assay. RESULTS: The nude mouse model of each cell line was inoculated successfully. The tumor growth rate and weight were significantly different among groups. After chemotherapy, abdominal cavity tumor growth inhibition rate was higher in BCT group (67%) compared to ADM and TNF groups, and similar to HepG2group (54%). MDRI and LRPmRNA could be detected in all groups, but TNF-α was detected only in TNF and BCT groups. Furthermore, MDR1 and LRP protein expression of tumors in TNF and BCT groups was low similar to HepG2 group. The apoptosis rate of hepatocarcinoma cells was much higher in BCT group than in other groups with TUNEL assay. CONCLUSION: BCT and TNF-a can reverse HCC MDR in nude mouse MDR1 model of liver neoplasm. 2005 The WJG Press and Elsevier Inc. All rights reserved 展开更多
关键词 BROMOCRIPTINE Tumor necrosis factor-α Hepatocellular carcinoma
下载PDF
Simple and Efficient Synthesis of Novel Glycosyl Thiourea Derivatives Derived from Thiophene as Potential Antitumor Agents
10
作者 Mohammed Mohsen Babatin Lotfi Khezami Abdel-Rahman Barakat Ahmed EI-Gazzar 《Journal of Chemistry and Chemical Engineering》 2011年第1期73-81,共9页
The practical synthesis of pseudonucleosides incorporating thiourea derivative by coupling of monosaccharides (D-glucose and D-galactose) per-O-acetylated glycosyl isothiocyanates and different heterocyclic hydrazid... The practical synthesis of pseudonucleosides incorporating thiourea derivative by coupling of monosaccharides (D-glucose and D-galactose) per-O-acetylated glycosyl isothiocyanates and different heterocyclic hydrazide derivatives is reported. The method involves the preparation ofper-O-acetylated glycosyl isothiocyanates from per-O-acetylated sugars (two-step synthesis), which couple with heterocyclic hydrazides from amines to give thiourea-linked pseudonucleosides. All newly synthesized pseudo-nucleosides were assayed against human lung cancer-cell lines (PG) and human liver cancer-cell lines (BEL-7402) in vitro. The 6,6-dimethyl-benzothiophen-3-carbo-hydrazide-4-one pseudonucleosides showed moderate inhibition against these two cancer-cell lines with ECs0 from 22.8 to 76.4 mM and from 54.9 to 82.4 mM, respectively. And the other compounds did not demonstrate any significant cytotoxicity even at concentrations up to 200 mM. 展开更多
关键词 Glycosyl bromides glycosyl isothiocyanates heterocyclic hydrazides thiourea-linked pseudooucleosides cytotoxicity.
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部